openPR Logo
Press release

Global Tuberculosis Testing Market Driven by Increasing Incidences of Tuberculosis and Rapid Culture Diagnostic Tests Worldwide

08-02-2017 02:22 PM CET | Health & Medicine

Press release from: Transparency Market Research

Global Tuberculosis Testing Market Driven by Increasing

A considerable portion of the population across geographies are suffering from a wide range of infectious diseases such as influenza, tuberculosis, AIDS, and several other bacterial and viral diseases. Tuberculosis or TB is one of the leading causes of death worldwide. Currently, organizations such as the World Health Organization (WHO) and the Foundation for Innovative New Diagnostics (FIND) have contributed largely towards improving global awareness regarding TB, its diagnosis, and available treatment options through TB control programs such as Stop TB. According to the WHO, in 2013, there were around 9 million new TB cases and close to 1.5 million TB deaths worldwide.

Obtain Report Details @ http://www.transparencymarketresearch.com/tuberculosis-testing-market.html

The global tuberculosis testing market has been categorized into seven segments based on major TB test types - smear microscopy, culture based tests, nucleic acid testing, Mantoux test, radiography (chest x-ray), drug susceptibility testing, and other tests such as serological tests, Interferon-Gamma Release Assays (IGRA), phage based tests, antigen-based tests, antibody-based tests, etc. Among such TB testing procedures available, culture based tests was the largest contributor in the global TB testing market.

Culture based TB tests include both solid as well as liquid culture tests that have been most widely accepted due to their relatively high specificity and accuracy than other TB tests available in the global market. However, other TB tests segment that includes IGRA, serological tests, and others is expected to register fastest growth during the forecast period from 2014 to 2020 due to many advantages such as fast result generation, high accuracy, requirement of single visit ,etc

The global tuberculosis testing market was valued at USD 1,936.1 million in 2013 and is expected to reach USD 2,619.4 million by 2020, growing at a CAGR of 4.3% from 2014 to 2020. Some of the major driving factors facilitating the growth of this market are increasing incidences of tuberculosis and the rising acceptance of new, innovative, and advanced molecular and rapid culture diagnostic tests worldwide. In addition, increased involvement of some of the world’s leading non-profit healthcare organizations for the development of new TB diagnostic tests would further boost the growth this market. Moreover, the TB diagnostics market is observed to be a propelling as many new product developers and manufacturers are expected to venture into the market with a robust pipeline of testing technologies.

Make an Enquiry @ http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=2267

Asia Pacific dominated the global tuberculosis testing market in 2013 followed by North America. Key factor responsible for Asia Pacific dominating the global TB testing market is the presence of a vast patient pool, which is growing at a rapid pace due to very high incidence rate of the disease, especially in some of the emerging economies of the region, such as India and China. In contrast, North America has a relatively smaller patient pool with lower disease incidences. However, higher awareness, well developed healthcare infrastructure, rapid acceptance of improved but expensive TB tests and better purchasing power are contributing towards the second highest market share of North America.

Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., F. Hoffmann-La Roche, Ltd., Hain Lifescience GmbH, bioMérieux SA, Hologic, Inc. QIAGEN, Akonni Biosystems, Inc., Abbott Laboratories, Alere, Inc., Cepheid, Epistem, Plc. and Sanofi are some of the major players operating in the global tuberculosis testing market. Among these, Becton, Dickinson and Company, Thermo Fisher Scientific, Inc, F. Hoffmann-La Roche Ltd. and Hain Lifescience GmbH are the leading players in this market aspiring to introduce novel TB testing technologies in the global market.

About Us

Transparency Market Research (TMR) is a global market intelligence company providing business information reports and services. The company’s exclusive blend of quantitative forecasting and trend analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of analysts, researchers, and consultants use proprietary data sources and various tools and techniques to gather and analyze information. Our business offerings represent the latest and the most reliable information indispensable for businesses to sustain a competitive edge.

Contact Us

Transparency Market Research
State Tower,
90 State Street, Suite 700
Albany, NY 12207
United States
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global Tuberculosis Testing Market Driven by Increasing Incidences of Tuberculosis and Rapid Culture Diagnostic Tests Worldwide here

News-ID: 652609 • Views:

More Releases from Transparency Market Research

Water Softening Systems Market Outlook 2035: Industry Set to Reach US$ 11.7 Billion with 6.3% CAGR
Water Softening Systems Market Outlook 2035: Industry Set to Reach US$ 11.7 Bill …
The global water softening systems market is experiencing significant growth as rising water hardness issues, increasing industrial water treatment needs, and growing residential adoption drive demand worldwide. Valued at US$ 6.0 billion in 2024, the market is projected to expand at a CAGR of 6.3% from 2025 to 2035, ultimately reaching US$ 11.7 billion by 2035. Key drivers include escalating concerns over scale formation in pipelines and appliances, stricter water
Vibrating Conveyor Market on Growth Path: USD 490.5 Mn in 2024 to USD 795.6 Mn by 2035
Vibrating Conveyor Market on Growth Path: USD 490.5 Mn in 2024 to USD 795.6 Mn b …
The Vibrating Conveyor Market is experiencing steady growth, driven by increasing adoption across industries such as food & beverages, automotive, mining, metallurgy, pharmaceuticals, packaging, and logistics. Vibrating conveyors are widely used for controlled material movement such as bulk solids, granules, powders and fragile products, enabling efficient handling with minimal damage. These systems provide smoother transfer, improved hygiene, precise feeding control, and lower maintenance compared to conventional mechanical conveyors, which is
Bleisure Travel Market to Reach USD 4,177.2 billion by 2035 | Growth Analysis & Opportunities
Bleisure Travel Market to Reach USD 4,177.2 billion by 2035 | Growth Analysis & …
The global Bleisure Travel Market is experiencing robust expansion as business trips increasingly merge with leisure activities, driven by rising corporate travel budgets, improved work-life balance priorities, and the growth of remote and flexible work cultures. The market was valued at approximately USD 692.7 billion in 2024 and is expected to witness strong growth over the next decade. Forecasts indicate that the market could reach nearly USD 4,177.2 billion by
Global Spiritual and Wellness Products Market to Reach US$ 9.6 Billion by 2034, Driven by Rising Focus on Holistic Well-Being and Mindfulness
Global Spiritual and Wellness Products Market to Reach US$ 9.6 Billion by 2034, …
The global spiritual and wellness products market is witnessing unprecedented growth as consumers around the world increasingly prioritize mental, emotional, physical, and spiritual well-being. According to the latest industry analysis, the market, valued at US$ 4.2 billion in 2023, is projected to expand at a CAGR of 8.0% from 2024 to 2034, ultimately reaching US$ 9.6 billion by 2034. This surge underscores a dramatic shift toward wellness-focused lifestyles and scientific

All 5 Releases


More Releases for Tuberculosis

Revolutionizing the Fight Against Tuberculosis: Global Anti-Tuberculosis Therape …
The global Anti-Tuberculosis (TB) Therapeutics Market is on the cusp of a transformative era, driven by urgent medical need, groundbreaking scientific advances, and expanding public-private partnerships. With an estimated 10 million new TB cases reported worldwide in 2022 and 1.4 million deaths, tuberculosis remains a leading infectious disease killer, commanding critical attention from healthcare providers, governments, and pharmaceutical innovators alike. As the world rallies to eliminate this centuries-old scourge, the
Latent Tuberculosis Infection Detection Market
Latent Tuberculosis Infection Detection Market worth $2.37 Bn by 2031 - Exclusive Report by InsightAce Analytic Pvt. Ltd. InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Latent Tuberculosis Infection Detection Market - (By Brand (QFT-Plus), By Test Type (Tuberculin Skin Test (TST), Interferon Gamma Release Assay (IGRA)), By Application, By End-use), Trends, Industry Competition Analysis, Revenue and Forecast To 2031." According to the latest research
Tuberculosis (TB) Diagnostics Market - Detect, Diagnose, Defeat: Innovating Solu …
Newark, New Castle, USA - new report, titled Tuberculosis (TB) Diagnostics Market The report has been put together using primary and secondary research methodologies, which offer an accurate and precise understanding of the Tuberculosis (TB) Diagnostics market. Analysts have used a top-down and bottom-up approach to evaluate the segments and provide a fair assessment of their impact on the global Tuberculosis (TB) Diagnostics market. The report offers an overview of
Conquering Tuberculosis: Exploring the Innovations in Mycobacterium Tuberculosis …
The global mycobacterium tuberculosis treatment market was valued at US$ 1.97 Bn in 2021 and is expected to increase at a CAGR of 1.2% over the forecast period 2022-2032. Mycobacterium tuberculosis is a bacteria that causes tuberculosis (TB), which mostly affects the lungs. Tuberculosis is a major public health crisis concern; however, it can be cured and prevented. Adults are most often affected by tuberculosis during their most productive years. Over
World Tuberculosis Day - Tuberculosis, the invisible pandemic
Tuberculosis is a disease that, every year, kills as many as COVID-19 does. March 24, World Tuberculosis Day, marks the anniversary of a momentous occasion - the discovery of the bacterium which causes tuberculosis in 1882. More than a hundred years after its discovery, tuberculosis is still a global health crisis. It is the leading cause of death from a single infectious disease agent, killing close to as many people per
Ocular Tuberculosis Therapeutics Market To Expand On Account Of Rising Tuberculo …
Research Nester released a report titled “Ocular Tuberculosis Therapeutics Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global ocular tuberculosis therapeutics market in terms of market segmentation by treatment, by end user and by region. Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model. Ocular tuberculosis is a type